By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Africa Housing NewsAfrica Housing News
Notification Show More
Aa
  • Home
  • News
  • Real Estate News
  • Nigeria Property News
  • Join Us
    • About Us
    • Contact Us
    • Join Us
Reading: Italian medical firm develops world’s first coronavirus vaccine
Share
Aa
Africa Housing NewsAfrica Housing News
  • Home
  • News
  • Real Estate News
  • Nigeria Property News
  • Join Us
Search
  • Home
  • News
  • Real Estate News
  • Nigeria Property News
  • Join Us
    • About Us
    • Contact Us
    • Join Us
Have an existing account? Sign In
Follow US
Africa Housing News > Blog > News > Italian medical firm develops world’s first coronavirus vaccine
News

Italian medical firm develops world’s first coronavirus vaccine

Fesadeb
Last updated: 2020/05/06 at 9:34 PM
Fesadeb Published May 6, 2020
Share
SHARE

An Italian medical firm, Takis said it has developed the world’s first vaccine that neutralises the coronavirus in human cells.

According to tests carried out at Rome’s infectious-disease Spallanzani Hospital, a single shot of the vaccine generates antibodies in mice.

Italian news agency ANSA reported that the antibodies can block the virus from infecting human cells.

Luigi Aurisicchio, CEO of Takis, told ANSA that the Covid-19 candidate vaccine had neutralised the virus in human cells, for the first time.

“According to Spallanzani Hospital, we are the first in the world so far to have demonstrated a neutralisation of the coronavirus by a vaccine.

“We expect this to happen in humans too,” Aurisicchio told ANSA.

After observing that five candidate vaccines generated a large number of antibodies, researchers selected the two with the best results.

All of the candidate vaccines currently being developed are based on the material genetic of DNA protein “spike”. They are injected with “electroporation” technique, which consists of an intramuscular injection followed by a brief electrical impulse, helping the vaccine enter the cells.

Researchers at Takis believe that this makes their vaccine particularly effective for generating antibodies in the lung cells, the most vulnerable to coronavirus.

Another Italian company ReiThera has said its coronavirus vaccine had shown a “strong immune response” in animals.

“The antibodies are able to prevent the infection and the T cells eliminate the virus that has already entered the organism,” it told news agency ANSA.

On Tuesday, Israel’s Defence Minister Naftali Bennett claimed the country’s main biological research institute IIBR has developed an antibody to the coronavirus that can attack the virus and neutralise it within the bodies of those who contract it.

The statement, however, did not clarify whether human trials for the vaccine were conducted.

The IIBR has conducted some clinical trials.

The researchers have identified the protein that is efficient in killing the virus in a patient’s body, and the institute would be publishing a paper soon about the findings.

So far, at least 254,532 people have died from Covid-19 since the outbreak first emerged in China last December.

More than 3,629,160 cases have been confirmed in 195 countries and territories.

PMnews

You Might Also Like

Ohanaeze Youths Hail Launch of Enugu Air, Say Mbah Unlocking Economic Opportunities

Ogun Government to Launch Environmental Watchdog to Tackle Floods, Waste, and Infrastructure Abuse

Governor Lawal Distributes 59,205 Bags of Fertiliser to Boost Agriculture in Zamfara

How NASS, FRC Collaboration Boosted GOEs’ Surplus from N200bn to Over N2trn

EFCC Uncovers Massive Fraud at NNPCL, Demands Crackdown on Unexplained Wealth

Join Our Whatsapp Group

Contact Image

Join Our WhatsApp Channel

Housing TV Africa is the First Housing News Television
in Africa on Startimes Channel 149 bringing you
Housing News, Mortgage News, Construction News etc

Fesadeb May 6, 2020 May 6, 2020
Share this Article
Facebook Twitter Email Print
1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© Africa Housing News. All Rights Reserved 2024

Welcome Back!

Sign in to your account

Lost your password?